https://www.thebodypro.com/category/adverse-events-comorbidities-hiv/tag/cancer

The Latest

doctor pointing at rectal model

Are Providers Ignoring Anal Sex as a Health Care Issue for Women at Risk for HIV and Cancer?

Recent studies examine the role anal sex is playing in HIV rates and anal cancer among women.

By Kenyon Farrow
discover opportunities

This Week in HIV Research: The Challenges of Our Assumptions

May 28, 2020: Anal lesion recurrence among women with HIV; non-alcoholic fatty liver disease frequency in lean patients; long-term efficacy for a smoking cessation intervention; non-lymphoid cancers following lymphoid malignancy.

By Barbara Jungwirth and Myles Helfand
polypharmacy

This Week in HIV Research: The Menace of Concomitance

April 16, 2020: Anticoagulants and antiretroviral boosters; durvalumab doesn't impair antiretroviral therapy; cigarette use and oral HPV incidence; using common labs to predict Kaposi sarcoma risk.

By Barbara Jungwirth and Myles Helfand
virology

This Week in HIV Research: Is Viral Suppression an STI Prevention Tool?

March 5, 2020: How U=U reduces more than HIV transmission; "other" HPV strain risks post-vaccination; vitamin E for nonalcoholic steatohepatitis; HCV therapy and increased cardiovascular risk.

By Barbara Jungwirth and Myles Helfand
woman in headscarf receiving chemotherapy in yellow room

This Week in HIV Research: A New Year, an Old Enemy

Jan. 2, 2020: Cancer treatment among people with HIV in the Obamacare era; chemotherapy, CD4 count, and mortality; cutting meds to cut costs; tailoring interventions on the microepidemic level.

By Barbara Jungwirth and Myles Helfand
Timothy Ray Brown at the Association of Nurses in AIDS Care (ANAC) in Portland, Oregon

The Berlin Patient, the First Person Ever Cured of HIV, on Taking PrEP: "I Want a Full Sexual Life"

Timothy Ray Brown, known as "the Berlin patient," has begun taking PrEP to make sure he doesn't have to deal with an HIV diagnosis -- again.

By Sony Salzman
doctor giving young person vaccine

HPV Vaccine Rates Are Low Because People Still Don't Understand Its Cancer Risks

The vaccine for human papillomavirus got a bad rap when it debuted. And yet time has shown it's very effective in reducing cancers linked to HPV.

By Martha Kempner
close up of man's arm getting blood drawn

We Have a Cure for Hepatitis C. Why Are Rates So High?

An in-depth update on what we know about HCV risk, symptoms, screening, outcomes, and treatment (including financial barriers).

By Martha Kempner
people in a doctor's office waiting room

This Week in HIV Research: The Reality of Disparity

Sept. 26, 2019: Racial disparities in the PrEP continuum; HIV and ocular syphilis; Kaposi sarcoma among people with well-suppressed HIV; modifiable risk factors in the management of chronic kidney disease.

By Barbara Jungwirth and Myles Helfand
doctor's gloved hands putting cotton swab test into sterile tube

HPV Rates Similar Among Gay and Bisexual Men and Cisgender Women

A new study adds to mounting evidence that all people should be screened and offered the vaccine for human papillomavirus.

By Martha Kempner